Core Viewpoint - Amphastar Pharmaceuticals reported quarterly earnings of $0.85 per share, exceeding the Zacks Consensus Estimate of $0.71 per share, but down from $0.94 per share a year ago, indicating an earnings surprise of +19.72% [1][2] Financial Performance - The company posted revenues of $174.41 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 2.69%, but down from $182.39 million year-over-year [2] - Over the last four quarters, Amphastar has surpassed consensus EPS estimates two times and topped consensus revenue estimates once [2] Stock Performance - Amphastar shares have declined approximately 43.9% since the beginning of the year, contrasting with the S&P 500's gain of 7.9% [3] Future Outlook - The company's earnings outlook is crucial for investors, with current consensus EPS estimates at $0.83 for the coming quarter and $3.17 for the current fiscal year [7] - The Zacks Rank for Amphastar is currently 2 (Buy), indicating expectations for the stock to outperform the market in the near future [6] Industry Context - The Medical - Generic Drugs industry, to which Amphastar belongs, is currently in the bottom 34% of over 250 Zacks industries, suggesting potential challenges ahead [8]

Core Viewpoint - Groupon (GRPN) has received an upgrade to a Zacks Rank 1 (Strong Buy), indicating a positive trend in earnings estimates which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system is based on changes in earnings estimates, which are closely correlated with near-term stock price movements [4][6]. - An increase in earnings estimates typically leads to higher fair value calculations by institutional investors, resulting in stock price movements [4]. Business Outlook - The upgrade in Groupon's rating suggests an improvement in the company's underlying business, which could lead to an increase in stock price as investors respond positively [5][10]. - For the fiscal year ending December 2025, Groupon is expected to earn $0.30 per share, with a significant increase of 265.5% in the Zacks Consensus Estimate over the past three months [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [7]. - Groupon's upgrade places it in the top 5% of Zacks-covered stocks, indicating strong potential for market-beating returns in the near term [10].

Core Viewpoint - TrueBlue (TBI) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive trend in earnings estimates which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system is based on changes in earnings estimates, which are strongly correlated with stock price movements, particularly due to institutional investors adjusting their valuations based on these estimates [4][6]. - TrueBlue's earnings estimates have been revised upward, with a 10.9% increase in the Zacks Consensus Estimate over the past three months, indicating an improvement in the company's business outlook [8][10]. Zacks Rating System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a proven track record of Zacks Rank 1 stocks generating an average annual return of +25% since 1988 [7]. - TrueBlue's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, suggesting potential for market-beating returns in the near term [9][10].

Group 1 - Shares of Cars.com (CARS) have increased by 4.7% over the past four weeks, closing at $13.13, with a mean price target of $17.08 indicating a potential upside of 30.1% [1] - The mean estimate consists of six short-term price targets with a standard deviation of $5.02, where the lowest estimate is $12.00 (an 8.6% decline) and the highest is $25.00 (a 90.4% increase) [2] - Analysts show strong agreement on the company's ability to report better earnings than previously predicted, which supports the potential for stock upside [4][11] Group 2 - The Zacks Consensus Estimate for the current year has risen by 0.8% over the past month, with one estimate increasing and no negative revisions [12] - CARS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for predicting stock gains, they can indicate the direction of price movement, which appears to be a useful guide [14]

Company Performance - Energy Fuels reported a quarterly loss of $0.1 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.04, marking an earnings surprise of -150.00% [1] - The company posted revenues of $4.21 million for the quarter ended June 2025, missing the Zacks Consensus Estimate by 55.19%, and a decline from $8.72 million in the same quarter last year [2] - Over the last four quarters, Energy Fuels has not surpassed consensus EPS estimates and has topped revenue estimates only once [2] Stock Movement and Outlook - Energy Fuels shares have increased approximately 93.4% since the beginning of the year, significantly outperforming the S&P 500's gain of 7.1% [3] - The company's earnings outlook will be crucial for future stock movements, with current consensus EPS estimates at -$0.04 on $8.9 million in revenues for the upcoming quarter and -$0.27 on $49.23 million in revenues for the current fiscal year [4][7] Industry Context - The Mining - Non Ferrous industry, to which Energy Fuels belongs, is currently ranked in the top 21% of over 250 Zacks industries, indicating a favorable industry outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Energy Fuels' stock performance [5]

Core Viewpoint - TIM S.A. Sponsored ADR (TIMB) has received an upgrade to a Zacks Rank 2 (Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][4]. Earnings Estimates and Revisions - The Zacks rating system is based on the changing earnings picture of a company, specifically tracking the Zacks Consensus Estimate for EPS from sell-side analysts [2]. - For the fiscal year ending December 2025, TIM is expected to earn $1.36 per share, which remains unchanged from the previous year, but the Zacks Consensus Estimate has increased by 1.9% over the past three months [9]. Impact of Institutional Investors - Changes in earnings estimates are strongly correlated with stock price movements, with institutional investors using these estimates to determine the fair value of shares, leading to buying or selling actions that affect stock prices [5]. Business Improvement Indicators - The upgrade in TIM's rating reflects an improvement in the company's underlying business, suggesting that investors may respond positively by driving the stock price higher [6]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a proven track record of Zacks Rank 1 stocks generating an average annual return of +25% since 1988 [8]. - TIM's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [11].

Shares of Pharming Group N.V. Sponsored ADR (PHAR) have gained 17.9% over the past four weeks to close the last trading session at $12.48, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $30.67 indicates a potential upside of 145.8%. The average comprises three short-term price targets ranging from a low of $14.00 to a high of $41.00, with a standard deviation of $14.57. While t ...

Shares of TTM Technologies (TTMI) have gained 2.9% over the past four weeks to close the last trading session at $43.85, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $56.75 indicates a potential upside of 29.4%. While the consensus price target is a much-coveted metric for investors, solely banking on this metric to make an investment decision may not be wise at all. That's b ...

Core Viewpoint - Thryv Holdings, Inc. (THRY) shows significant upside potential with a mean price target of $21.4, indicating a 60.2% increase from the current price of $13.36 [1] Price Targets and Analyst Consensus - The average price target consists of five estimates ranging from a low of $16.00 to a high of $26.00, with a standard deviation of $4.1, suggesting variability in analyst predictions [2] - The lowest estimate indicates a potential increase of 19.8%, while the highest suggests a 94.6% upside [2] - A low standard deviation indicates strong agreement among analysts regarding the stock's price movement direction [9] Earnings Estimates and Analyst Optimism - Analysts have shown increasing optimism about THRY's earnings prospects, as evidenced by a strong consensus in revising EPS estimates higher [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 27%, with no negative revisions [12] - THRY holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are a common tool for investors, they can often mislead, as empirical research shows they rarely indicate actual stock price movements [7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]

While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective. Bearing this in mind, let's now explore the average estimates of specific Maximus metrics that are commonly monitored and projected by Wall Street analysts. Analysts on Wall Street project that Maximus (MMS) will announce quarterly earnings of $1.39 per share ...